Advanced or metastatic HER2-positive breast cancer

Active Ingredient: Neratinib

Indication for Neratinib

Population group: only adults (18 years old or older)
Therapeutic intent: Adjunct intent

Neratinib in combination with capecitabine is indicated for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting.

For this indication, competent medicine agencies globally authorize below treatments:

240 mg once daily until disease progression or unacceptable toxicities

For:

Dosage regimens

Oral, 240 milligrams neratinib, once daily to meals.

Detailed description

Premedication for diarrhea

When not using dose escalation, administer antidiarrheal prophylaxis during the first 56 days of treatment and initiate with the first dose of neratinib.

Instruct patients to take loperamide as directed in Table 1. Titrate loperamide to 1–2 bowel movements per day.

Table 1. Loperamide Prophylaxis:

Time on neratinib Loperamide Dose and Frequency
Weeks 1–2 (days 1–14) 4 mg three times daily
Weeks 3–8 (days 15–56) 4 mg twice daily
Weeks 9–Discontinuation of neratinib 4 mg as needed, not to exceed 16 mg per day;
titrate dosing to achieve 1–2 bowel movements
per day

If diarrhea occurs despite prophylaxis, treat with additional antidiarrheals, fluids and electrolytes as clinically indicated. neratinib dose interruptions and dose reductions may also be required to manage diarrhea.

Recommended dose and schedule

The recommended dose of neratinib is 240 mg given orally once daily with food on Days 1–21 of a 21-day cycle plus capecitabine (750 mg/m² given orally twice daily) on Days 1–14 of a 21-day cycle until disease progression or unacceptable toxicities.

Dose escalation

A two-week dose escalation for neratinib may be considered instead of starting at the 240 mg daily dose for patients with early-stage breast cancer and metastatic breast cancer, as described in Table 2.

Table 2. Neratinib Dose Escalation and Treatment Schedule:

Time on neratinib Neratinib Dose
Week 1 (days 1–7) 120 mg daily
Week 2 (days 8–14) 160 mg daily
Week 3 and onwards 240 mg daily

If diarrhea occurs, treat with antidiarrheal medications, fluids, and electrolytes as clinically indicated. Neratinib dose interruptions and dose reductions may also be required to manage diarrhea.

Administration instructions

Instruct patients to take neratinib at approximately the same time every day.

If a patient misses a dose, do not replace missed dose, and instruct the patient to resume neratinib with the next scheduled daily dose.

Active ingredient

Neratinib

Neratinib is an irreversible pan–erythroblastic leukaemia viral oncogene homolog (ERBB) tyrosine kinase inhibitor (TKI) that blocks mitogenic growth factor signal transduction through covalent, high affinity binding to the ATP binding site of 3 epidermal growth factor receptors (EGFRs): EGFR (encoded by ERBB1), HER2 (encoded by ERBB2), and HER4 (encoded by ERBB4) or their active heterodimers with HER3 (encoded by ERBB3). This results in sustained inhibition of these growth promoting pathways with HER2-amplified or over-expressed, or HER2-mutant breast cancers.

Read more about Neratinib

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.